Munier F, Balmer A, von Moos C, Pescia G, Gailloud C, van Melle G, Thonney F, Gaide A C, Allaz M J, Rutz H P
Hôpital Ophthalmique Universitaire Jules Gonin, Lausanne.
Klin Monbl Augenheilkd. 1991 May;198(5):419-24. doi: 10.1055/s-2008-1045999.
Activity and phenotype of red blood cell esterase D were systematically determined in a population of 128 retinoblastoma patients from 99 families and compared to 158 controls, in order to detect a chromosome 13q14 deletion. Among these patients 12 were healthy carriers and 116 affected carriers of a mutant allele of the retinoblastoma susceptibility gene (110 retinoblastoma, 5 retinoma, 1 phtisis bulbi). 4 patients were found to have decreased ESD levels in connection with 13q14 deletion which was confirmed by chromosome analysis. The data presented here suggest that ESD quantification has a high specificity and sensitivity for the detection of homogenous chromosome 13 deletions in retinoblastoma patients.